Immune Enhancement of Skin Carcinogenesis by CD4+ T Cells

D Daniel, N Meyer-Morse, EK Bergsland… - The Journal of …, 2003 - rupress.org
D Daniel, N Meyer-Morse, EK Bergsland, K Dehne, LM Coussens, D Hanahan
The Journal of experimental medicine, 2003rupress.org
In a transgenic model of multi-stage squamous carcinogenesis induced by human
papillomavirus (HPV) oncogenes, infiltrating CD4+ T cells can be detected in both
premalignant and malignant lesions. The lymph nodes that drain sites of epidermal
neoplasia contain activated CD4+ T cells predominantly reactive toward Staphylococcal
bacterial antigens. HPV16 mice deficient in CD4+ T cells were found to have delayed
neoplastic progression and a lower incidence of tumors. This delay in carcinogenesis is …
In a transgenic model of multi-stage squamous carcinogenesis induced by human papillomavirus (HPV) oncogenes, infiltrating CD4+ T cells can be detected in both premalignant and malignant lesions. The lymph nodes that drain sites of epidermal neoplasia contain activated CD4+ T cells predominantly reactive toward Staphylococcal bacterial antigens. HPV16 mice deficient in CD4+ T cells were found to have delayed neoplastic progression and a lower incidence of tumors. This delay in carcinogenesis is marked by decreased infiltration of neutrophils, and reduced activity of matrix metalloproteinase-9, an important cofactor for tumor progression in this model. The data reveal an unexpected capability of CD4 T cells, whereby, proinflammatory CD4+ T cells, apparently responding to bacterial infection of dysplastic skin lesions, can inadvertently enhance neoplastic progression to invasive cancer.
rupress.org